📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Hycor Biomedical

1.1 - Company Overview

Hycor Biomedical Logo

Hycor Biomedical

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of diagnostic systems and assays for allergy and mast cell activation, including NOVEOS for allergy testing with small sample volumes; NOVEOS assay reagents, consumables, and supplies for specific IgE tests; a Tryptase Assay chemiluminescent microparticle immunoassay for serum tryptase detection; and TASSO+, a capillary blood collection device compatible with NOVEOS.

Products and services

  • Tryptase Assay: A laboratory-grade chemiluminescent microparticle immunoassay detecting tryptase levels in human serum, indicating mast cell activation
  • NOVEOS Assay Reagents, Consumables, and Supplies: A system-specific set of products used with NOVEOS for conducting specific IgE allergy tests, encompassing assay reagents, consumables, and supplies
  • NOVEOS: A clinical-grade diagnostic system for allergy testing that uses a small sample size and reduces errors related to insufficient sample quantities, working with TASSO+ for less invasive collection

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Hycor Biomedical

Vera Therapeutics Logo

Vera Therapeutics

HQ: United States Website
  • Description: Provider of biologic therapeutics, including atacicept, a recombinant fusion protein containing the soluble TACI receptor that binds the cytokines BAFF and APRIL, used to treat IgA nephropathy and lupus nephritis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vera Therapeutics company profile →
Equillium Logo

Equillium

HQ: United States Website
  • Description: Provider of therapeutics for autoimmune and inflammatory disorders, including itolizumab, a clinical-stage monoclonal antibody targeting the CD6-ALCAM pathway; EQ101, a tri-specific cytokine inhibitor of IL-2/IL-9/IL-15 in Phase 2 for alopecia areata; EQ302, an oral bi-specific inhibitor of IL-15/IL-21 in pre-clinical; and a multi-cytokine platform generating composite peptides to selectively block key cytokines at shared receptors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Equillium company profile →
Provention Bio Logo

Provention Bio

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical solutions dedicated to sourcing, developing, and commercializing novel therapeutics and cutting-edge approaches to intercept and prevent immune-mediated disease, using a predict-and-prevent model to intervene before disease onset.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Provention Bio company profile →
Epirus Biopharma Logo

Epirus Biopharma

HQ: United States Website
  • Description: Provider of biosimilar monoclonal antibodies and therapeutic proteins for emerging markets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Epirus Biopharma company profile →
Medsenic Logo

Medsenic

HQ: France Website
  • Description: Provider of drug development and manufacturing focused on drugs for the treatment of autoimmune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medsenic company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Hycor Biomedical

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Hycor Biomedical

2.2 - Growth funds investing in similar companies to Hycor Biomedical

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Hycor Biomedical

4.2 - Public trading comparable groups for Hycor Biomedical

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Hycor Biomedical

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Hycor Biomedical

What does Hycor Biomedical do?

Hycor Biomedical is a provider of diagnostic systems and assays for allergy and mast cell activation, including NOVEOS for allergy testing with small sample volumes; NOVEOS assay reagents, consumables, and supplies for specific IgE tests; a Tryptase Assay chemiluminescent microparticle immunoassay for serum tryptase detection; and TASSO+, a capillary blood collection device compatible with NOVEOS.

Who are Hycor Biomedical's competitors?

Hycor Biomedical's competitors and similar companies include Vera Therapeutics, Equillium, Provention Bio, Epirus Biopharma, and Medsenic.

Where is Hycor Biomedical headquartered?

Hycor Biomedical is headquartered in United States.

How many employees does Hycor Biomedical have?

Hycor Biomedical has 1,000 employees 🔒.

When was Hycor Biomedical founded?

Hycor Biomedical was founded in 2010 🔒.

What sector and industry vertical is Hycor Biomedical in?

Hycor Biomedical is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Hycor Biomedical

Who are the top strategic acquirers in Hycor Biomedical's sector and industry

Top strategic M&A buyers and acquirers in Hycor Biomedical's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Hycor Biomedical?

Top strategic M&A buyers groups and sectors for Hycor Biomedical include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Hycor Biomedical's sector and industry vertical

Which are the top PE firms investing in Hycor Biomedical's sector and industry vertical?

Top PE firms investing in Hycor Biomedical's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Hycor Biomedical's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Hycor Biomedical's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Hycor Biomedical's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Hycor Biomedical include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Hycor Biomedical's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Hycor Biomedical?

The key public trading comparables and valuation benchmarks for Hycor Biomedical include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Hycor Biomedical for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Hycor Biomedical with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Hycor Biomedical's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Hycor Biomedical with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Hycor Biomedical's' sector and industry vertical?

Access recent funding rounds and capital raises in Hycor Biomedical's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Hycor Biomedical

Launch login modal Launch register modal